🔎 Trials Near Me

Почетна › Рак дојке › Охајо › Cleveland

Kliničke studije za Рак дојке u gradu Cleveland, OH

33 studija za Рак дојке traži učesnike na lokacijama u gradu Cleveland i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

Тражи се учесникФаза 3
  • University Hospitals Seidman Cancer Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT05696626

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

Тражи се учесникФаза 1
  • Cleveland Clinic Foundation, Cleveland
Узраст од 18 до 55 · Жене · Ажурирано 12. 11. 2026. · NCT07310420

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Тражи се учесникФаза 3
  • Case Western Reserve University, Cleveland
  • Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
  • Cleveland Clinic Foundation, Cleveland
  • и још 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03418961

Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

Тражи се учесникФаза 1/2
  • Research Facility, Cleveland
Сви узрасти · Оба пола · Ажурирано 12. 11. 2026. · NCT06590857

The Vanguard Study: Testing a New Way to Screen for Cancer

Тражи се учесникЗдраве особе су добродошле
  • Louis Stokes Cleveland VA Medical Center, Cleveland
Узраст од 45 до 75 · Оба пола · Ажурирано 6. 11. 2026. · NCT06995898

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Тражи се учесникФаза 1
  • Cleveland Clinic, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07029399

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Тражи се учесник
  • Cleveland Clinic, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07214532

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Тражи се учесникФаза 3
  • University Hospitals Cleveland Medical Center, Cleveland
  • Fairview Hospital, Cleveland
  • Cleveland Clinic - Hillcrest Hospital, Mayfield Heights · 12 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07174336

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Тражи се учесникФаза 3
  • Fairview Hospital, Cleveland
  • Cleveland Clinic Foundation, Cleveland
  • Hillcrest Hospital, Mayfield Heights · 12 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06790693

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Тражи се учесникФаза 2
  • Cleveland Clinic - Oncology Department, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06760819

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Тражи се учесникФаза 3
  • Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
  • Cleveland Clinic Foundation, Cleveland
  • South Pointe Hospital, Warrensville Heights · 9 ми удаљено
  • и још 1
Узраст од 18 до 60 · Жене · Ажурирано 4. 11. 2026. · NCT05879926

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

Тражи се учесникОпсервациона студија
  • University Hospitals Seidman Cancer Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT05974150

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

Тражи се учесникФаза 1
  • Cleveland Clinic Taussig Cancer Institute, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06774963

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Тражи се учесникФаза 1/2
  • UH Cleveland Medical Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07109726

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Тражи се учесникОпсервациона студија
  • Cleveland Clinic Main Campus, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT06401421

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

Тражи се учесникФаза 1/2
  • Cleveland Clinic Taussig Cancer Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT07100106

The Cancer of the Pancreas Screening-5 CAPS5)Study

Тражи се учесникФаза 3
  • Case Comprehensive Cancer Center, Case Western Medical Reserve, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT02000089

Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease

Тражи се учесникФаза 2
  • Cleveland Clinic, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT06875128

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Тражи се учесникФаза 1/2
  • The Cleveland Clinic Taussig Cancer Center, Cleveland
Узраст 12 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT04585750

Study of AVZO-021 in Patients With Advanced Solid Tumors

Тражи се учесникФаза 1/2
  • Avenzo Therapeutics Recruiting Site, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT05867251

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Тражи се учесникФаза 1/2
  • Cleveland Clinic, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 23. 9. 2026. · NCT06618287

Study to Investigate Efficacy of a Novel Probiotic on the Bacteriome and Mycobiome of Breast Cancer

Тражи се учесник
  • Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland
Узраст од 18 до 65 · Жене · Ажурирано 15. 9. 2026. · NCT04362826

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Тражи се учесникФаза 1
  • University Hospital Cleveland Medical Center, Cleveland
  • Cleveland Clinic, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 9. 9. 2026. · NCT06253871

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Тражи се учесникФаза 3
  • Cleveland Clinic, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 2. 9. 2026. · NCT06072612

Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast

Тражи се учесникФаза 2
  • University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
  • Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center, Cleveland
Узраст 19 и старији · Оба пола · Ажурирано 6. 8. 2026. · NCT06129747

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

Тражи се учесникФаза 2
  • Case Western Reserve University, Cleveland
Узраст од 18 до 55 · Жене · Ажурирано 27. 7. 2026. · NCT06184750

TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients

Тражи се учесник
  • Case Western Reserve University/University Hospitals Cleveland, Cleveland
Узраст 65 и старији · Жене · Ажурирано 17. 7. 2026. · NCT05535192

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Тражи се учесникФаза 1/2
  • UH Cleveland Medical Center, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 7. 7. 2026. · NCT05768139

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Тражи се учесникФаза 2
  • Cleveland Clinic, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 6. 5. 2026. · NCT01042379

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Тражи се учесникФаза 3
  • Case Western Reserve University, Cleveland
  • MetroHealth Medical Center, Cleveland
  • Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
  • и још 3
Узраст од 50 до 70 · Оба пола · Ажурирано 23. 4. 2026. · NCT04852887

Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer

Тражи се учесникФаза 1/2
  • Cleveland Clinic, Cleveland
Узраст 18 и старији · Оба пола · Ажурирано 22. 4. 2026. · NCT05455619

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Тражи се учесникОпсервациона студија
  • Massive Bio SYNERGY-AI site, Mayfield Heights · 12 ми удаљено
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774

Studije za Рак дојке u drugim gradovima

Ostale studije u gradu Cleveland

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.